Gaze Contingent Attentional Reinforcement in Major Depressive Disorder
ConditionMajor Depressive Disorder (MDD)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorTel Aviv University
About this trial
The main objective of this randomized controlled trial is to evaluate whether a gaze-contingent feedback task using negative reinforcement can serve as an effective attention-modification procedure and contribute to the treatment of Major Depressive Disorder (MDD).
Eligibility criteria
Qualifiers
Primary diagnosis of MDD
MADRS>=7
Normal or corrected-t-normal vision
Disqualifiers
Present or past psychosis, manic or hypomanic episode, PTSD
High suicidal ideation or behavior
Severe alcohol or cannabis use disorder, and/or any severity of other substance use disorder (exepct nicotine use)
Pharmacological treatment if not stabilized for at least three months or concurrent psychotherapy
Trial design
Treatments tested in this trial
- Aversive white noise
- Music reward
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov